Medical Animation Anesthetics

Treating Severe Pain With Sea Snail Saliva
Scientists have developed a new version of a medication, first isolated from the saliva of sea snails, that could be taken in pill form to relieve the most severe forms of pain as effectively as morphine but without risking addiction. An article on the topic appears in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine...

NeurogesX Progresses On Coverage For Qutenza®
NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced important progress in the implementation of its reimbursement strategy for Qutenza® (capsaicin) 8% patch. Qutenza is currently available in the United States for the management of neuropathic pain associated with postherpetic neuralgia (PHN)...

Tumor Growth Blocked By Morphine
Current research suggests that taking morphine can block new blood vessel and tumor growth. The related report by Koodie et al, "Morphine suppresses tumor angiogenesis through a HIF1α/p38MAPK pathway," appears in the August 2010 issue of the American Journal of Pathology. Morphine is currently the gold standard of analgesics used to relieve severe pain and suffering...

Antarctic Octopus Venom Studied By Scientists
Researchers have collected venom from octopuses in Antarctica for the first time, significantly advancing our understanding of the properties of venom as a potential resource for drug-development...

Adherence To Recommended Exercise Improves Physical Function, Reduces Pain For OA Patients
Patients with osteoarthritis (OA) of the knee or hip who adhere to the recommended home physical therapy exercises and physically active lifestyle experience more improvement in pain, physical function, and self-perceived effect according to a study from researchers in The Netherlands...

Anesthesia Type May Impact Whether Total Hip Or Knee Replacement Patients Contract A Surgical Site Infection
A study appearing in the August 2010 issue of Anesthesiology found that patients receiving a total hip or knee replacement in Taiwan had a higher incidence of surgical site infections (SSIs) when general anesthesia was administered for the operation than when the same procedures were performed under epidural/spinal (regional) anesthesia...

European Medicines Agency Concludes Review Of Modified-Release Oral Opioids Of The WHO Level III Scale For The Management Of Pain
The European Medicines Agency has finalised a review of modified-release oral opioids of the WHO level III scale for the management of pain...

Sickle Cell Treatment Developed At LA BioMed Enters Phase 3 Clinical Trial
An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute (LA BioMed) has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO have announced . Researchers throughout the U.S...

Panel Turns Down FDA Proposal To Control Prescription Narcotic Painkillers
An FDA (Food and Drug Administration), USA Advisory Committee voted 25 to 10 against a proposal to reduce the abuse and misuse of long-acting narcotic painkillers, such as OxyContin or Vicodin. Although the Advisory Committee's recommendations are not binding the FDA usually follows them when making a regulatory decision...

Hepatitis Virus Transmission Through Misuse Of Anesthesia
Hepatitis B virus (HBV) and hepatitis C virus (HCV) can be transmitted during intravenous (IV) administration of anesthesia, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. In this study, doctors found that anesthesia contamination - not endoscopy contamination - was the cause of infection...

Impax Laboratories Receives Final FDA Approval For Generic OPANA(R) ER Tablets
Impax Laboratories, Inc. (NASDAQ:IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of OPANA® ER (oxymorphone hydrochloride) Extended Release 30mg tablet. In June 2010, the Company was granted final approval for the 5mg, 10mg, 20mg, and 40mg tablets...

Inhibitex Reports Independent Data Safety Monitoring Board Recommends Continuation Of Phase II Clinical Trial Of FV-100
Inhibitex, Inc. (Nasdaq: INHX) announced that the independent data safety monitoring board (DSMB) responsible for reviewing safety data from the Company's ongoing Phase II clinical trial of FV-100 met, as scheduled, after the Company had provided it with complete 30-day follow-up safety data on the third quartile (75%) of the patients that the Company plans to enroll in the trial...

Diagnostic "Guidelines" A Barrier To Prompt Relief For Some Back Pain
Slavishly following long-held guidelines for diagnosing the cause of arthritis-related back pain is resulting in excessive tests, delays in pain relief and wasteful spending of as much as $10,000 per patient, new Johns Hopkins-led research suggests...

Novel Treatment For Pain In Sickle Cell Disease
A University of Minnesota Medical School research team led by Kalpna Gupta, Ph.D., has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease (SCD)...

Chronic Facial Pain, Diagnosis And Treatment
Do you suffer from chronic facial pain, including constant pain in or around your ears, sore jaw, ringing in your ears, clicking or popping sounds when you open or close your mouth or chronic headaches and neck pain? Do you often feel like your jaw is stuck open or closed? Do you feel as though you have a limited opening of your mouth? If you answered "yes" to any of the abo...